Drosophila Gene Signature Predicts Breast Cancer Survival
Author Information
Author(s): Damasco Christian, Lembo Antonio, Somma Maria Patrizia, Gatti Maurizio, Di Cunto Ferdinando, Provero Paolo
Primary Institution: Molecular Biotechnology Center and Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy
Hypothesis
Can a gene expression signature derived from Drosophila mitotic genes predict survival in breast cancer patients?
Conclusion
The Drosophila mitotic signature is highly predictive of survival in breast cancer patients and highlights cytokinesis as an important prognostic marker.
Supporting Evidence
- The DM signature has minimal overlap with existing signatures.
- It outperforms many widely used breast cancer signatures in predictive power.
- Increased expression of DM signature genes is negatively correlated with patient survival.
- Cytokinesis-related genes contribute significantly to the predictive power of the DM signature.
Takeaway
Scientists found that certain genes from fruit flies can help predict how well breast cancer patients will do. This means they can help doctors decide on the best treatments.
Methodology
The study constructed a gene expression signature using human orthologues of Drosophila genes and analyzed their predictive power across multiple breast cancer datasets.
Potential Biases
Potential biases may arise from the selection of datasets and the merging of datasets with overlapping patients.
Limitations
The study primarily focused on breast cancer and may not be applicable to other cancer types without further validation.
Participant Demographics
The study included breast cancer patients from various datasets, with a focus on lymph-node negative patients.
Statistical Information
P-Value
3eā6
Confidence Interval
1.08ā1.60
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website